What is Cybele Microbiome?
Cybele Microbiome is a pioneering entity dedicated to advancing skin health by elucidating the microbiome's critical role in managing inflammation, bolstering infection defense, and facilitating wound healing. The company champions the use of ingredients that foster a beneficial microbiome environment, thereby enhancing product efficacy and minimizing adverse reactions in dermatological applications. Through strategic collaborations with leading scientific minds and the execution of rigorous clinical trials, Cybele Microbiome substantiates the tangible benefits of its innovations for skin well-being. This scientifically-grounded approach establishes the company as a frontrunner in the evolving skincare landscape, advocating for a harmonious interplay with the skin's natural microbial ecosystem.
How much funding has Cybele Microbiome raised?
Cybele Microbiome has raised a total of $24K across 1 funding round:
Debt
$24K
Debt (2021): $24K with participation from PPP
What's next for Cybele Microbiome?
With the recent influx of substantial expansion capital, Cybele Microbiome is poised for significant growth and market penetration. The company's strategic focus will likely involve scaling its research and development initiatives, expanding its product pipeline, and potentially broadening its market reach through strategic partnerships or acquisitions. The significant Series B/C stage funding indicates investor confidence in Cybele Microbiome's business model and its potential to disrupt the traditional skincare industry by leveraging cutting-edge microbiome research. Future endeavors may include further clinical validation, international market expansion, and the development of novel therapeutic and cosmetic solutions.
See full Cybele Microbiome company page
